Welcome to our dedicated page for Synergy Chc news (Ticker: SNYR), a resource for investors and traders seeking the latest updates and insights on Synergy Chc stock.
Synergy CHC Corp (SNYR) delivers innovative consumer health solutions through herbal detox products and nutritional supplements. This news hub provides investors and industry observers with essential updates about the company's operations in the competitive wellness market.
Access official press releases and curated analysis covering product developments, retail partnerships, and financial performance. Our collection features updates on SNYR's dual distribution strategy combining direct e-commerce sales with expanded retail availability through major health stores.
Key content includes earnings announcements, new product formulations, strategic collaborations, and regulatory milestones. Bookmark this page for real-time updates about SNYR's initiatives in natural health solutions and digital commerce innovation.
Synergy CHC Corp (NASDAQ: SNYR) reported its Q4 and full-year 2024 financial results, marking its eighth consecutive quarter of profitability. Q4 2024 showed revenue of $10.3M (down 22% YoY), with net income of $105.7K and EPS of $0.01. Full-year 2024 results included revenue of $34.8M (down 19% YoY), net income of $2.1M, and EPS of $0.28.
The company completed its IPO in October 2024, offering 1,150,000 shares at $9.00 per share. Notable developments include expanded partnerships with BJ's Wholesale Clubs and Publix, reduced debt by $4.5M in Q4, and the appointment of Jaime Fickett as permanent CFO. The revenue decline was primarily attributed to FOCUSfactor rebranding and retailer de-inventorying, which the company states is now behind them as they enter 2025.
Synergy CHC Corp. (NASDAQ: SNYR), a consumer health care and lifestyle products provider, has scheduled the release of its Q4 and full year 2024 financial results for Monday, March 31, 2025, before market opening.
The company will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT on the same day, featuring CEO Jack Ross and CFO Jaime Fickett. Participants are encouraged to join 15 minutes before the start time. The call will be accessible through a live webcast on Synergy's Investor Relations website, with a replay available for a time.
Synergy CHC Corp (NASDAQ: SNYR), a consumer health care and lifestyle products provider, has announced its participation in the upcoming 37th Annual ROTH Conference. The event will take place from March 16-18, 2025, in Dana Point, California.
The company's management team will be available during the conference for one-on-one meetings with investors. Interested parties are advised to contact their ROTH sales representative to schedule meetings.
Synergy CHC Corp. (NASDAQ: SNYR) reported its Q3 2024 financial results, marking its seventh consecutive profitable quarter. Revenue decreased 34% to $7.1 million compared to $10.8 million in Q3 2023, primarily due to retailer de-inventorying related to FOCUSfactor product rebranding.
Key financial metrics include: gross margin of 67.2% (down from 72.0%), operating income of $1.1 million (down from $2.1 million), and net income of $0.8 million (down from $1.3 million). The company completed its IPO of 1,150,000 shares at $9.00 per share and expanded retail partnerships with BJ's Wholesale Clubs and Publix. Post-IPO, Synergy reduced debt by $3.1 million and added $6.2 million in net cash to its balance sheet.
Synergy CHC Corp. (NASDAQ: SNYR) has scheduled the release of its third quarter 2024 financial results for December 6, 2024, before market opening. The company will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT on the same day, featuring CEO Jack Ross and CFO Stacy Bieber. Participants are encouraged to join the call 15 minutes early, and a webcast replay will be available on the company's website.
Synergy CHC Corp (NASDAQ: SNYR) has completed its initial public offering of 1,150,000 shares of common stock at $9.00 per share. Trading began on the Nasdaq Global Market on October 23, 2024, under ticker 'SNYR'. The company raised approximately $8.4 million in net proceeds after deducting underwriting costs. Underwriters have a 30-day option to purchase up to 172,500 additional shares. The funds will be used to repay related party promissory notes and for general corporate purposes. Roth Capital Partners served as the sole manager for the offering.
Synergy CHC Corp, a provider of consumer health care, beauty, and lifestyle products, has announced the pricing of its initial public offering of 1,150,000 shares at $9.00 per share. Trading will commence on Nasdaq Global Market under symbol 'SNYR' on October 23, 2024. The company expects to receive $8.4 million in net proceeds, potentially reaching $9.9 million if underwriters exercise their option to purchase additional 172,500 shares. Proceeds will be used to repay related party promissory notes and for general corporate purposes. Roth Capital Partners is serving as the sole manager for the offering, which is expected to close on October 24, 2024.
